Novo Nordisk A/S (NVO) Analysts | Reuters.com
Edition:
United States

Novo Nordisk A/S (NVO)

NVO on New York Consolidated

51.06USD
24 Jun 2016
Change (% chg)

$-2.34 (-4.38%)
Prev Close
$53.40
Open
$50.85
Day's High
$52.08
Day's Low
$50.83
Volume
1,592,819
Avg. Vol
1,418,979
52-wk High
$60.34
52-wk Low
$46.17

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy 0.58 December 25 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.00 1.00 1.00 1.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 1 4,287.71 4,287.71 4,287.71 --
Quarter Ending Sep-16 1 4,338.23 4,338.23 4,338.23 --
Year Ending Dec-16 2 16,991.90 17,295.50 16,688.20 16,772.20
Year Ending Dec-17 2 18,054.20 18,382.00 17,726.50 --
Earnings (per share)
Quarter Ending Jun-16 1 0.58 0.58 0.58 --
Quarter Ending Sep-16 1 0.59 0.59 0.59 --
Year Ending Dec-16 2 2.28 2.32 2.24 2.14
Year Ending Dec-17 2 2.47 2.51 2.43 --
LT Growth Rate (%) 1 11.70 11.70 11.70 15.50

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 4,135.45 4,026.29 109.16 2.64
Quarter Ending Dec-15 4,222.15 4,240.00 17.85 0.42
Quarter Ending Sep-15 4,061.66 3,992.01 69.65 1.71
Quarter Ending Sep-14 4,026.43 3,960.32 66.11 1.64
Quarter Ending Jun-14 3,929.14 3,975.00 45.86 1.17
Earnings (per share)
Quarter Ending Mar-16 0.55 0.55 0.00 0.00
Quarter Ending Dec-15 0.47 0.48 0.01 2.13
Quarter Ending Sep-15 0.47 0.49 0.02 3.40
Quarter Ending Mar-14 0.43 0.45 0.02 4.46
Quarter Ending Mar-12 0.29 0.29 0.00 0.27

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 4,287.71 4,300.29 4,300.29 4,392.43 --
Quarter Ending Sep-16 4,338.23 4,350.95 4,350.95 4,416.83 --
Year Ending Dec-16 16,991.90 17,017.20 17,192.20 17,361.40 16,772.20
Year Ending Dec-17 18,054.20 18,081.20 18,176.90 18,374.50 --
Earnings (per share)
Quarter Ending Jun-16 0.58 0.58 0.58 0.59 --
Quarter Ending Sep-16 0.59 0.59 0.59 0.59 --
Year Ending Dec-16 2.28 2.28 2.28 2.28 2.14
Year Ending Dec-17 2.47 2.47 2.47 2.49 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 0 1 0 1
Quarter Ending Sep-16 0 1 0 1
Year Ending Dec-16 0 1 0 2
Year Ending Dec-17 0 1 0 2
Earnings
Quarter Ending Jun-16 0 0 0 0
Quarter Ending Sep-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 1 0 1

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Stock Traders Daily
$20.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.